| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/29/2004 | US20040019182 Reagents and methods for assaying Bacillus anthracis lethal factor protease |
| 01/29/2004 | US20040019066 Methionine salvage pathway in bacillus |
| 01/29/2004 | US20040019016 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor |
| 01/29/2004 | US20040019015 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 01/29/2004 | US20040019006 Diagnosis, analyzing neuropathic pain; genetic engineered polypeptides |
| 01/29/2004 | US20040019005 Methods for parallel measurement of genetic variations |
| 01/29/2004 | US20040019004 Anticancer agents; antitumor agents |
| 01/29/2004 | US20040018999 Methods and compositions for RNA interference |
| 01/29/2004 | US20040018983 Binding to zinc finger domain protein |
| 01/29/2004 | US20040018973 Diagnosis cell proliferation; binding antibody to nucleic acids |
| 01/29/2004 | US20040018969 Genetic engineering; central nervous system disorders |
| 01/29/2004 | US20040018643 Encoded random arrays matrices |
| 01/29/2004 | US20040018626 Replacement of immunoglobulin in endogenous cells; forming embryos stem cell |
| 01/29/2004 | US20040018624 Compositions and methods for making mutations in cell lines and animals |
| 01/29/2004 | US20040018612 Electro-optical devices and methods for hybridization and detection |
| 01/29/2004 | US20040018605 Anticancer agents; autoimmune diseases; central nervous system disorders; polymerase chain reactions |
| 01/29/2004 | US20040018584 Fluorescence measurement of water samples; heat treatment; incubation; applying activating wavelengths |
| 01/29/2004 | US20040018583 Method of monitoring biofouling in membrane separation systems |
| 01/29/2004 | US20040018582 Genes and gene products that confer susceptibility to vancomycin derivative antibiotics and methods and assays for identifying bifunctional glycopeptide antibiotics using same |
| 01/29/2004 | US20040018580 Serine protease complex; immobilization; anticancer, antitumor agents |
| 01/29/2004 | US20040018578 Ex Vivo method for determination of CETP activity and efficacy of heart disease treatment |
| 01/29/2004 | US20040018574 Molecular differences between species of the M. tuberculosis complex |
| 01/29/2004 | US20040018572 Mutant Plk protein and gene encoding the same |
| 01/29/2004 | US20040018570 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth |
| 01/29/2004 | US20040018567 Proteins; antiproliferative agent; autoimmune disease; antiinflammatory agents |
| 01/29/2004 | US20040018565 Contacting with labels; analyzing; amplification of signal |
| 01/29/2004 | US20040018562 Enzyme as membrane receptor; determining binding |
| 01/29/2004 | US20040018561 Peptide compounds and their use as protease substrates |
| 01/29/2004 | US20040018553 Reagents and methods useful for detecting diseases of the prostate |
| 01/29/2004 | US20040018552 Immobilization; controlling length; coupling to label; biosynthesis |
| 01/29/2004 | US20040018551 Purification of Dna, Rna; hydration, mixing with chaotropic agent and reducing agents; heating controlling temperature; polymerase chain reaction, amplification |
| 01/29/2004 | US20040018550 Antibodies immunologically specific for a DNA repair endonuclease and methods of use thereof |
| 01/29/2004 | US20040018548 Gold bonded to Dna as detector; measuring fluorescence; concave, convex pattern on surface |
| 01/29/2004 | US20040018547 Ion channel receptor and uses thereof |
| 01/29/2004 | US20040018546 Using labeled fluid; medical diagnosis |
| 01/29/2004 | US20040018542 Phosphodiesterase enzymes |
| 01/29/2004 | US20040018540 Evaluation method of interferon beta treatment against multiple sclerosis |
| 01/29/2004 | US20040018539 Oligonucleotides for use in determining the presence of human papilloma virus in a test sample |
| 01/29/2004 | US20040018538 Mitochondrial dosimeter |
| 01/29/2004 | US20040018537 Genes for detecting bacteria and a method for detecting bacteria by using the genes |
| 01/29/2004 | US20040018536 Molecule for assigning genotype to phenotype and components thereof as well as method for constructing assigning molecule and method for utilizing assigning molecule |
| 01/29/2004 | US20040018535 Determination, calibration; using computer |
| 01/29/2004 | US20040018533 Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions |
| 01/29/2004 | US20040018531 Methods of identifying and isolating stem cells and cancer stem cells |
| 01/29/2004 | US20040018530 In vitro evolution of functional RNA and DNA using electrophoretic selection |
| 01/29/2004 | US20040018528 Cancer diagnosis |
| 01/29/2004 | US20040018527 Differential patterns of gene expression that predict for docetaxel chemosensitivity and chemo resistance |
| 01/29/2004 | US20040018526 Labelling Dna; immobilization on substrate; detecting damage |
| 01/29/2004 | US20040018525 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasma |
| 01/29/2004 | US20040018524 Method of screening for genes that influence pathological conditions or survival of animals infected with pathogen |
| 01/29/2004 | US20040018522 Identification of dysregulated genes in patients with multiple sclerosis |
| 01/29/2004 | US20040018521 Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease |
| 01/29/2004 | US20040018519 Anticancer agents; using adsorber; vapor phase spectrometry |
| 01/29/2004 | US20040018518 Analyzing Dna sequences; genetic engineering; measurement glyphosate tolerance in plant |
| 01/29/2004 | US20040018515 Quantitative analysis; using nucleic acids; binding to aptamer |
| 01/29/2004 | US20040018514 Nucleotide sequence derived from Listeria inocua |
| 01/29/2004 | US20040018513 Methods of assigning a subject affected by leukemia to a leukemia risk group, predicting whether a subject affected by leukemia has an increased risk of relapse, increased risk of developing secondary acute myeloid leukemia; kits |
| 01/29/2004 | US20040018512 Methods of enriching for and identifying polymorphisms |
| 01/29/2004 | US20040018511 Genetic markers and polymorphisms in the bovine somatostatin (SST) locus, as well as haplotypes that are associated with certain desirable traits such as marbling |
| 01/29/2004 | US20040018510 Human calcium channel compositions and methods |
| 01/29/2004 | US20040018509 Involves obtaining a sample peripheral blood from a pregnant woman, treating the sample of peripheral blood such that the fetal DNA present in the fetal nucleated cells is made available for detection |
| 01/29/2004 | US20040018506 Methods and systems for ordering assays which detect gene expression; collections of stock assays are assembled using pre- and post- manufacturing quality control procedures and made available to consumers via the Internet |
| 01/29/2004 | US20040018504 Method for extracting quantitative information relating to interactions between cellular components |
| 01/29/2004 | US20040018502 Method for analyzing a target nucleic acid fragment and a kit for analyzing a target nucleic acid fragment |
| 01/29/2004 | US20040018499 Human extracellular messengers (XMES) and polynucleotides which identify and encode XMES; methods for diagnosing, treating or preventing disorders associated with aberrant expression of XMES |
| 01/29/2004 | US20040018497 Human obesity LIPIN3 polynucleotide and polypeptide sequences and methods of use thereof |
| 01/29/2004 | US20040018496 Detection of bacterial kidney disease |
| 01/29/2004 | US20040018495 Microparticle based signal amplification for the detection of analytes |
| 01/29/2004 | US20040018494 Isothermal transcription based amplification assay for detection and quantification of guanylyl cyclase C |
| 01/29/2004 | US20040018493 Genetic variants of the human CD3 antigen, epsilon subunit (CD3E) gene and methods for identifying which variant(s) of this gene is/are possessed by an individual |
| 01/29/2004 | US20040018492 Detection of nucleotide polymorphisms; discrimination of perfectly matched probe-target hybrids |
| 01/29/2004 | US20040018491 Detection of nucleic acid reactions on bead arrays |
| 01/29/2004 | US20040018489 Detection of RNA |
| 01/29/2004 | US20040018488 Detection of human herpes virus 6 (HHV6) |
| 01/29/2004 | US20040018487 Methods of diagnosing cervical cancer |
| 01/29/2004 | US20040018215 Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 01/29/2004 | US20040018196 Proteins and nucleic acids encoding same |
| 01/29/2004 | US20040018150 Screening prodrugs of methoxyphosphonate nucleotide analogues to identify prodrugs selectively targeting desired tissues with antiviral or antitumor activity. This method has led to the identification of novel mixed ester-amidates of PMPA for |
| 01/29/2004 | US20040018149 Methods for cultivating dermal fibroblasts, methods for preparing in vitro dermis equivalents, methods for preparing three-dimensional in vitro skin equivalents, an in vitro dermis equivalent, a three dimensional in vitro skin |
| 01/29/2004 | US20040016642 Biosensor |
| 01/29/2004 | DE19964268B4 Verfahren zum Screenen einer Verbindung, welche die Wechselwirkung zwischen IGF-1R und einem der Polypeptide IIP-1 bis IIP-10 hemmt A method for screening a compound which inhibits the interaction between IGF-1R and IIP-one of the polypeptides 1 to IIP-10 |
| 01/29/2004 | DE19738908B4 Verfahren zur Bestimmung individueller genetischer Einflüsse für Schadstoffeinwirkungen und/oder Planung eines Therapiekonzeptes für neurodermitis- und/oder asthmagefährdete oder -erkrankte Personen A method for determining individual genetic influences for toxic effects and / or planning of a treatment strategy for atopic dermatitis and / or asthma endangered or -erkrankte people |
| 01/29/2004 | DE10232902A1 Verfahren zum Identifizieren von Inhibitoren des 20S und 26S Proteasoms A method for identifying inhibitors of 20S and 26S proteasome |
| 01/29/2004 | DE10229391A1 METASTACHIP: ein Biochip zur Bestimmung des metastatischen Potentials von Tumoren METASTACHIP: a biochip for determining the metastatic potential of tumors |
| 01/29/2004 | DE10229379A1 EG-VEGF Rezeptor Antagonisten EG-VEGF receptor antagonists |
| 01/29/2004 | CA2496253A1 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 01/29/2004 | CA2494727A1 Capture and detection of microbes by membrane methods |
| 01/29/2004 | CA2493919A1 Quantitative multiplex amplification on a genomic scale, and applications for detecting genomic rearrangements |
| 01/29/2004 | CA2493808A1 Methods for identifying small molecules that modulate premature translation termination and nonsense mediated mrna decay |
| 01/29/2004 | CA2493768A1 Embryonic stem cell markers and uses thereof |
| 01/29/2004 | CA2493679A1 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | CA2493572A1 Methods and compositions for activating or inhibiting vegf-d and vegf-c |
| 01/29/2004 | CA2493560A1 Method and apparatus for manipulating polarizable analytes via dielectrophoresis |
| 01/29/2004 | CA2493461A1 Drug discovery method |
| 01/29/2004 | CA2493263A1 Novel gene associated with rheumatoid arthritis |
| 01/29/2004 | CA2492899A1 Biosensor arrays and methods |
| 01/29/2004 | CA2492598A1 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | CA2492498A1 Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/29/2004 | CA2492238A1 Method for identifying cellular growth inhibitors |
| 01/29/2004 | CA2492178A1 Exopeptidase-mediated unquenching of reporter substrates in assays for kinase and phosphatase activity |